A Finnish company has announced the development of a new carbon-neutral protein powder called Solein, derived from carbon dioxide, water, and solar energy. Similar in appearance and taste to wheat, the potential uses for the protein are exciting.

Prof Sewell said the 'right people' are now interested in developing the potential new therapy and said progress could now move 'quite fast'. The team says human trials on terminally ill patients could begin as early as November if the new treatment passes further laboratory safety testing.

Summary: A link between liver dysfunction and Alzheimer's disease has been discovered. The findings add to the understanding of the role metabolic dysfunction plays in the neurodegenerative disease.

Seeing cells through a DNA lens, bringing new autism genes to the forefront, mining tuberculosis mutants for new treatment options, and more.